Sofieke Klamer

1.3k total citations
21 papers, 597 citations indexed

About

Sofieke Klamer is a scholar working on Infectious Diseases, Hepatology and General Health Professions. According to data from OpenAlex, Sofieke Klamer has authored 21 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 5 papers in Hepatology and 4 papers in General Health Professions. Recurrent topics in Sofieke Klamer's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 epidemiological studies (4 papers) and COVID-19 Clinical Research Studies (4 papers). Sofieke Klamer is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 epidemiological studies (4 papers) and COVID-19 Clinical Research Studies (4 papers). Sofieke Klamer collaborates with scholars based in Belgium, Sweden and Netherlands. Sofieke Klamer's co-authors include Carlijn Voermans, Mara de Sain, Klaas Bouwmeester, A. Gouget, Hervé Canut, R. Weide, Francine Govers, Steven Van Gucht, Lorenzo Subissi and Vanessa Suin and has published in prestigious journals such as The FASEB Journal, The Lancet Infectious Diseases and PLoS Pathogens.

In The Last Decade

Sofieke Klamer

21 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofieke Klamer Belgium 13 165 160 125 77 56 21 597
F Kazazi Australia 12 57 0.3× 268 1.7× 211 1.7× 28 0.4× 28 0.5× 17 838
Tami Halperin Israel 12 61 0.4× 668 4.2× 217 1.7× 45 0.6× 11 0.2× 21 960
A. Mühlbacher Austria 14 43 0.3× 321 2.0× 143 1.1× 126 1.6× 59 1.1× 26 826
M. R. Macnaughton United Kingdom 21 42 0.3× 812 5.1× 201 1.6× 56 0.7× 24 0.4× 40 1.2k
Anjali Singh India 14 19 0.1× 231 1.4× 102 0.8× 47 0.6× 15 0.3× 60 636
Christopher W. Wong Singapore 12 30 0.2× 188 1.2× 290 2.3× 7 0.1× 11 0.2× 16 845
Braira Wahid Pakistan 11 10 0.1× 272 1.7× 96 0.8× 72 0.9× 9 0.2× 45 560
Andrés F. Vallejo United Kingdom 15 16 0.1× 120 0.8× 118 0.9× 17 0.2× 8 0.1× 39 742
Weixian Chen China 9 14 0.1× 111 0.7× 218 1.7× 34 0.4× 3 0.1× 29 500

Countries citing papers authored by Sofieke Klamer

Since Specialization
Citations

This map shows the geographic impact of Sofieke Klamer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofieke Klamer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofieke Klamer more than expected).

Fields of papers citing papers by Sofieke Klamer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofieke Klamer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofieke Klamer. The network helps show where Sofieke Klamer may publish in the future.

Co-authorship network of co-authors of Sofieke Klamer

This figure shows the co-authorship network connecting the top 25 collaborators of Sofieke Klamer. A scholar is included among the top collaborators of Sofieke Klamer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofieke Klamer. Sofieke Klamer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Catteau, Lucy, Sofieke Klamer, Katrien Latour, et al.. (2023). COVID-19 Clusters in Belgian Nursing Homes: Impact of Facility Characteristics and Vaccination on Cluster Occurrence, Duration and Severity. Viruses. 15(1). 232–232. 4 indexed citations
2.
Janssens, Raphaël, Sofieke Klamer, Bavo Verhaegen, et al.. (2022). SARS-CoV-2 Surveillance in Belgian Wastewaters. Viruses. 14(9). 1950–1950. 10 indexed citations
3.
Oyen, Herman Van, Koen Blot, Lucy Catteau, et al.. (2022). Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data. BMC Infectious Diseases. 22(1). 839–839. 6 indexed citations
4.
Braeye, Toon, Sofieke Klamer, Emmanuel Robesyn, et al.. (2022). COVID-19 contact tracing in Belgium: main indicators and performance, January – September 2021. Archives of Public Health. 80(1). 118–118. 16 indexed citations
5.
Klamer, Sofieke, Nina Van Goethem, Daniel Thomas, et al.. (2021). Prioritisation for future surveillance, prevention and control of 98 communicable diseases in Belgium: a 2018 multi-criteria decision analysis study. BMC Public Health. 21(1). 192–192. 12 indexed citations
6.
Fischer, Natalie, Ilse Peeters, Sofieke Klamer, et al.. (2021). Prevalence estimates of genital Chlamydia trachomatis infection in Belgium: results from two cross-sectional studies. BMC Infectious Diseases. 21(1). 947–947. 3 indexed citations
7.
Goethem, Nina Van, Chloé Wyndham-Thomas, Lucy Catteau, et al.. (2021). Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients. Archives of Public Health. 79(1). 185–185. 12 indexed citations
8.
Dupont, Yves, Sofieke Klamer, Javiera Rebolledo, et al.. (2021). One year of laboratory-based COVID-19 surveillance system in Belgium: main indicators and performance of the laboratories (March 2020–21). Archives of Public Health. 79(1). 188–188. 18 indexed citations
9.
Verbeeck, Johan, Sofieke Klamer, Tinne Lernout, et al.. (2021). Confirmed COVID-19 Cases per Economic Activity during Autumn Wave in Belgium. International Journal of Environmental Research and Public Health. 18(23). 12489–12489. 14 indexed citations
10.
Hoxha, Ana, Chloé Wyndham-Thomas, Sofieke Klamer, et al.. (2020). Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities. The Lancet Infectious Diseases. 21(4). e67–e67. 34 indexed citations
11.
Subissi, Lorenzo, et al.. (2019). Subtype-specific differences in the risk of hospitalisation among patients infected with hepatitis E virus genotype 3 in Belgium, 2010–2018. Epidemiology and Infection. 147. e224–e224. 27 indexed citations
12.
Papadopoulos, Theofilos, Sofieke Klamer, Boudewijn Catry, et al.. (2019). The health and economic impact of acute gastroenteritis in Belgium, 2010–2014. Epidemiology and Infection. 147. e146–e146. 9 indexed citations
13.
Suin, Vanessa, Sofieke Klamer, Veronik Hutse, et al.. (2019). Epidemiology and genotype 3 subtype dynamics of hepatitis E virus in Belgium, 2010 to 2017. Eurosurveillance. 24(10). 36 indexed citations
14.
Klamer, Sofieke, Marion Kleijer, Dirk Geerts, et al.. (2018). TGFBI Expressed by Bone Marrow Niche Cells and Hematopoietic Stem and Progenitor Cells Regulates Hematopoiesis. Stem Cells and Development. 27(21). 1494–1506. 12 indexed citations
15.
Pol, Jonathan, Sofieke Klamer, James Ahodantin, et al.. (2015). Alternative splicing‐regulated protein of hepatitis B virus hacks the TNF‐α‐stimulated signaling pathways and limits the extent of liver inflammation. The FASEB Journal. 29(5). 1879–1889. 17 indexed citations
16.
Klamer, Sofieke & Carlijn Voermans. (2014). The role of novel and known extracellular matrix and adhesion molecules in the homeostatic and regenerative bone marrow microenvironment. Cell Adhesion & Migration. 8(6). 563–577. 72 indexed citations
17.
Klamer, Sofieke, Carlijn Kuijk, Peter L. Hordijk, et al.. (2013). BIGH3 modulates adhesion and migration of hematopoietic stem and progenitor cells. Cell Adhesion & Migration. 7(5). 434–449. 23 indexed citations
18.
Centlivre, Mireille, Nicolas Legrand, Sofieke Klamer, et al.. (2013). Preclinical In Vivo Evaluation of the Safety of a Multi-shRNA-based Gene Therapy Against HIV-1. Molecular Therapy — Nucleic Acids. 2. e120–e120. 38 indexed citations
19.
Bouwmeester, Klaas, Mara de Sain, R. Weide, et al.. (2011). The Lectin Receptor Kinase LecRK-I.9 Is a Novel Phytophthora Resistance Component and a Potential Host Target for a RXLR Effector. PLoS Pathogens. 7(3). e1001327–e1001327. 187 indexed citations
20.
Bouwmeester, Klaas, et al.. (2008). Lectin receptor kinase 79, a putative target of the Phytophthora infestans effector IPI-O. Socio-Environmental Systems Modeling. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F Kazazi Breakdown of academic impact, for papers by Tami Halperin Breakdown of academic impact, for papers by A. Mühlbacher Breakdown of academic impact, for papers by M. R. Macnaughton Breakdown of academic impact, for papers by Anjali Singh Breakdown of academic impact, for papers by Christopher W. Wong Breakdown of academic impact, for papers by Braira Wahid Breakdown of academic impact, for papers by Andrés F. Vallejo Breakdown of academic impact, for papers by Weixian Chen
Rankless by CCL
2026